An attempt by the United States to produce a low-cost, non-patented COVID-19 vaccine

An attempt by the United States to produce a low-cost, non-patented COVID-19 vaccine

Scientists in Texas, USA, are working together to develop a new low - cost, non - proprietary COVID - 19 vaccine.

The aim is to develop a vaccine that is more readily available to everyone in the world. According to scientists at the Baylor Medical College Vaccine Development Children's Hospital in Texas, their goal is to develop the vaccine, following a common practice that has been around for decades.

They say the idea is to produce and distribute it at a lower price accordingly. It is hoped that this will increase the vaccination rate worldwide, especially in poorer countries.

According to foreign media reports, the team has been developing prototypes for the Sars and Mers viruses since 2011. In the future, they will introduce a new vaccine for the COVID-19 virus, called the Corbevax or the world's COVID-19 vaccine.

The scientists point out that more than 60 vaccines can be manufactured using the same technology, and that the idea of ​​not having a patent for these vaccines makes it possible for anyone to reproduce the vaccine. Meanwhile. India has already approved the Corbevax vaccine, which has been successfully tested clinically in 33 locations across the country for 3,000 people between the ages of 18 and 80. -